Med Schools, Training Programs Eschew Pharma Funds

References 

1. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295:429–433
   • CrossRef
2. American College of Rheumatology. ACR REF/Amgen/Wyeth Rheumatology Fellowship Training Award. http://www.rheumatology.org/ref/awards/rhemtrnfell.aspAccessed June 29, 2009
3. Croasdale M. Drug firms to fund residency slots in dermatology pilot program. American Medical News. July 18, 2005;
4. Mundy A. Pressured, schools review ties to drug firms. Wall Street Journal. Sept. 11, 2008;
5. AMA Council on Ethical and Judicial Affairs. Industry support of professional education in medicine (Report 1 of the Council on Ethical and Judicial Affairs). http://www.ama-assn.org/ama1/pub/upload/mm/471/ceja1-2.docAccessed June 22, 2009
6. American Association of Medical Colleges. Industry Funding of Medical Education: Report of an AAMC Task Force. Washington, DC June 19, 2008;
7. Pharmaceutical Research and Manufacturers of America. Code on interactions with healthcare professionals. Washington, DC July 10, 2008;
8. Lo B, Field M. Conflict of interest in medical research, education, and practice. Washington, DC: Institute of Medicine; 2009;
9. AMA Council on Ethical and Judicial Affairs. Financial relationships with industry in continuing medical education (REPORT 1 OF THE COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS (A-09)). http://www.ama-assn.org/ama1/pub/upload/mm/475/ceja01a09.pdfAccessed June 22, 2009
10. American Medical Students Association. PharmFree Scorecard. http://www.amsascorecard.org/executive-summaryAccessed June 24, 2009